Marksans Pharma consolidated net profit declines 8.75% in the September 2021 quarter

Sales rise 1.33% to Rs 361.20 crore

Net profit of Marksans Pharma declined 8.75% to Rs 46.29 crore in the quarter ended September 2021 as against Rs 50.73 crore during the previous quarter ended September 2020. Sales rose 1.33% to Rs 361.20 crore in the quarter ended September 2021 as against Rs 356.47 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales361.20356.47 1 OPM %16.6423.33 -PBDT67.1684.89 -21 PBT59.7865.90 -9 NP46.2950.73 -9

Powered by Capital Market - Live News